IDSA : View All Letters on Adult and Adolescent Immunization(2)

11/15/2004

Stimulating Innovation in Medical Technologies (PDF)

IDSA urged HHS to develop an initiative to stimulate innovation in medical technologies, specifically new drugs, vaccines, and diagnostics to treat, prevent, and detect infectious diseases agents, and particularly for antibiotics to treat resistant bacterial infections and new rapid diagnostics to detect them.

10/29/2004

Concern about the Hypothetical Association between Thimerosal in Vaccines and Autism (PDF)

IDSA opposes the actions of some congressional members who inaccurately propose an association between vaccines containing the preservative thimerosal and autism.

05/23/2003

Improved Vaccine Affordability and Availability (PDF)

IDSA supported legislation that would ensure the future stability of the national Vaccine Injury Compensation Program (VICP).

06/04/2002

IDSA Outlines its Research Priorities for NIH Director Elias Zerhouni, MD (PDF)

IDSA joined with HIVMA to support the development of new therapeutics, vaccines, diagnostics and approaches; investigation of the chronic diseases/infectious agents link; global tuberculosis, malaria and HIV/AIDS research; research capacity/infrastructure building in resource-limited nations; the Fogarty International Center; international ID training opportunities; and domestic HIV/AIDS therapeutic research.

07/10/2000

Scientific Advisory Committee Funding (PDF)

IDSA urged Congress not to cut funding for several federal vaccine-related advisory committees.

View All Letters on Adult and Adolescent Immunization

Stimulating Innovation in Medical Technologies (PDF)

Concern about the Hypothetical Association between Thimerosal in Vaccines and Autism (PDF)

Improved Vaccine Affordability and Availability (PDF)

IDSA Outlines its Research Priorities for NIH Director Elias Zerhouni, MD (PDF)

Scientific Advisory Committee Funding (PDF)

Infectious Diseases Society of America